Lesion Sterilization and Tissue Repair Antibiotic Paste Versus Zinc Oxide and Eugenol Pulpectomy for Treatment of Primary Molars With Pulp Necrosis
LSTR
1 other identifier
interventional
180
0 countries
N/A
Brief Summary
The goal of this clinical trial is to compare the efficacy of lesion sterilization and tissue repair (LSTR) antibiotic paste versus zinc oxide eugenol (ZOE) pulpectomy for the treatment of primary molars with pulp necrosis in pediatric patients. The main questions it aims to answer are:
- Is LSTR antibiotic paste (CTZ paste) effective in treating primary molars with pulp necrosis?
- Is ZOE pulpectomy effective in treating primary molars with pulp necrosis, and how does its efficacy compare with LSTR therapy? Researchers will compare LSTR therapy (Group A) with ZOE pulpectomy (Group B) to determine which treatment provides better clinical and radiographic outcomes after six months. Participants will:
- Be randomly assigned to one of the two treatment groups after diagnosis of pulp necrosis in primary molars.
- Receive treatment under standard behavior management techniques with local anesthesia following topical application of 2% lignocaine gel and rubber dam isolation.
- Undergo either Lesion Sterilization and Tissue Repair (LSTR) therapy with CTZ paste or zinc oxide eugenol (ZOE) pulpectomy according to group allocation.
- Return for a clinical and radiographic follow-up evaluation after six months to assess treatment outcomes.
- Allow researchers to record their clinical findings and radiographic results to evaluate the efficacy of both treatment methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
March 19, 2026
March 1, 2026
7 months
March 11, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants with Clinical Success
Clinical success will be assessed based on the absence of sinus tract, soft tissue swelling, or edema associated with the treated primary molar during follow-up clinical examination.
6 months
Number of Participants with Radiographic Success
Radiographic success will be assessed by reduction or complete disappearance of the initial periapical radiolucency and absence of any newly developed radiolucency on follow-up periapical radiographs of the treated tooth.
6 months after treatment
Secondary Outcomes (1)
Reduction in Periapical Radiolucency
baseline and 6 months
Study Arms (2)
LSTR therapy
EXPERIMENTALParticipants in this group receive CTZ antibiotic paste placed in the pulp chamber after irrigation.
Zinc Oxide Eugenol (ZOE) Pulpectomy
ACTIVE COMPARATORParticipants in this group receive conventional pulpectomy with ZOE paste placed in the root canals.
Interventions
Placement of CTZ antibiotic paste (chloramphenicol, tetracycline, zinc oxide mixed with eugenol) in the pulp chamber after irrigation with 3% sodium hypochlorite, followed by restoration with resin-modified glass ionomer cement.
Intervention: Conventional pulpectomy including working length determination, canal debridement with K-files and 3% sodium hypochlorite irrigation, followed by obturation with zinc oxide eugenol paste and final restoration with resin-modified glass ionomer cement.
Eligibility Criteria
You may qualify if:
- Children of both genders
- years and 10 years
- Pulp necrosis in mandibular primary molars with minimum of 2/3 of the roots
- Consent from Parents/Guardian of children.
- Sufficient crown structure for restoration
You may not qualify if:
- Children who have a physical or mental change.
- Involving systemic illnesses.
- History of allergy to drugs being utilized
- Antibiotics use within three months
- Teeth with aberrant root resorption or pulp canal obliteration on periapical radiography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 16, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
March 19, 2026
Record last verified: 2026-03